Merck & Co., Inc. is 29.4x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($293.16 B vs $9.96 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ARWR | MRK |
|---|---|---|
| Market cap | $9.96 B | $293.16 B |
| US-listed rank | #941 | #44 |
| Revenue (latest FY) | $829.45M | $65.01B |
| Net income (latest FY) | -$1.63M | $18.25B |
| Net margin | -0.2% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 1,347 | 996 |
Merck & Co., Inc. is 29.4x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($293.16 B vs $9.96 B).
In their latest fiscal years, ARROWHEAD PHARMACEUTICALS, INC. reported $829.45M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: ARROWHEAD PHARMACEUTICALS, INC. and Merck & Co., Inc., or browse the full rankings.